Literature DB >> 26343109

Cancer: A Problem of Developmental Biology; Scientific Evidence for Reprogramming and Differentiation Therapy.

Stewart Sell, Andrea Nicolini, Paola Ferrari, Pier M Biava1.   

Abstract

Current medical literature acknowledges that embryonic micro-environment is able to suppress tumor development. Administering carcinogenic substances during organogenesis in fact leads to embryonic malformations, but not to offspring tumor growth. Once organogenesis has ended, administration of carcinogenic substances causes a rise in offspring tumor development. These data indicate that cancer can be considered a deviation in normal development, which can be regulated by factors of the embryonic microenvironment. Furthermore, it has been demonstrated that teratoma differentiates into normal tissues once it is implanted in the embryo. Recently, it has been shown that implanting a melanoma in Zebrafish embryo did not result in a tumor development; however, it did in the adult specimen. This demonstrates that cancer cells can differentiate into normal tissues when implanted in the embryo. In addition, it was demonstrated that other tumors can revert into a normal phenotype and/or differentiate into normal tissue when implanted in the embryo. These studies led some authors to define cancer as a problem of developmental biology and to predict the present concept of "cancer stem cells theory". In this review, we record the most important researches about the reprogramming and differentiation treatments of cancer cells to better clarify how the substances taken from developing embryo or other biological substances can induce differentiation of malignant cells. Lastly, a model of cancer has been proposed here, conceived by one of us, which is consistent with the reality, as demonstrated by a great number of researches. This model integrates the theory of the "maturation arrest" of cancer cells as conceived by B. Pierce with the theory which describes cancer as a process of deterministic chaos determined by genetic and/or epigenetic alterations in differentiated cells, which leads a normal cell to become cancerous. All the researches here described demonstrated that cancer can be considered a problem of developmental biology and that one of the most important hallmarks of cancer is the loss of differentiation as already described by us in other articles.

Entities:  

Mesh:

Year:  2016        PMID: 26343109     DOI: 10.2174/1389450116666150907102717

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  16 in total

Review 1.  Marine Mollusk-Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance.

Authors:  Maria Letizia Ciavatta; Florence Lefranc; Marianna Carbone; Ernesto Mollo; Margherita Gavagnin; Tania Betancourt; Ramesh Dasari; Alexander Kornienko; Robert Kiss
Journal:  Med Res Rev       Date:  2016-12-07       Impact factor: 12.944

2.  Aneuploid embryonic stem cells exhibit impaired differentiation and increased neoplastic potential.

Authors:  Meili Zhang; Li Cheng; Yuyan Jia; Guang Liu; Cuiping Li; Shuhui Song; Allan Bradley; Yue Huang
Journal:  EMBO J       Date:  2016-08-24       Impact factor: 11.598

3.  m6A Topological Transition Coupled to Developmental Regulation of Gene Expression During Mammalian Tissue Development.

Authors:  Shanshan Li; Qing Yang; Rui Jiao; Pengfei Xu; Yazhou Sun; Xin Li
Journal:  Front Cell Dev Biol       Date:  2022-07-05

Review 4.  The Extracellular Matrix Stiffening: A Trigger of Prostate Cancer Progression and Castration Resistance?

Authors:  Carole Luthold; Tarek Hallal; David P Labbé; François Bordeleau
Journal:  Cancers (Basel)       Date:  2022-06-11       Impact factor: 6.575

Review 5.  Malignant Melanoma: Autoimmunity and Supracellular Messaging as New Therapeutic Approaches.

Authors:  Ion G Motofei
Journal:  Curr Treat Options Oncol       Date:  2019-05-06

6.  Developmental Stage-Specific Embryonic Induction of HepG2 Cell Differentiation.

Authors:  Yanning Li; Yanhong Zong; Zhigang Xiao; Mengxuan Zhu; Hui Xiao; Jinsheng Qi; Kun Liu; Hui Wang
Journal:  Dig Dis Sci       Date:  2015-12-14       Impact factor: 3.199

7.  Epstein-Barr virus microRNA BART10-3p promotes dedifferentiation and proliferation of nasopharyngeal carcinoma by targeting ALK7.

Authors:  Wei-Jie Luo; Shi-Wei He; Wen-Qing Zou; Yin Zhao; Qing-Mei He; Xiao-Jing Yang; Rui Guo; Yan-Ping Mao
Journal:  Exp Biol Med (Maywood)       Date:  2021-08-23

8.  Bioinformatics Analysis Reveals Distinct Molecular Characteristics of Hepatitis B-Related Hepatocellular Carcinomas from Very Early to Advanced Barcelona Clinic Liver Cancer Stages.

Authors:  Fan-Yun Kong; Xiao Wei; Kai Zhou; Wei Hu; Yan-Bo Kou; Hong-Juan You; Xiao-Mei Liu; Kui-Yang Zheng; Ren-Xian Tang
Journal:  PLoS One       Date:  2016-07-25       Impact factor: 3.240

9.  An epithelial marker promoter induction screen identifies histone deacetylase inhibitors to restore epithelial differentiation and abolishes anchorage independence growth in cancers.

Authors:  H M Tang; K T Kuay; P F Koh; M Asad; T Z Tan; V Y Chung; S C Lee; J P Thiery; Ry-J Huang
Journal:  Cell Death Discov       Date:  2016-06-13

10.  Long glucocorticoid-induced leucine zipper regulates human thyroid cancer cell proliferation.

Authors:  Emira Ayroldi; Maria Grazia Petrillo; Maria Cristina Marchetti; Lorenza Cannarile; Simona Ronchetti; Erika Ricci; Luigi Cari; Nicola Avenia; Sonia Moretti; Efisio Puxeddu; Carlo Riccardi
Journal:  Cell Death Dis       Date:  2018-02-21       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.